Key result
Patients undergoing cancer surgery face a high risk of venous thromboembolism but frequently do not receive adequate thromboprophylaxis, prompting a review of available preventive measures.
Why the study?
What are the available measures for thromboprophylaxis in patients undergoing cancer surgery?
What are the available measures for thromboprophylaxis in patients undergoing cancer surgery?
This review highlights the increased risk of VTE in cancer surgery patients and summarizes guideline-directed thromboprophylaxis options.
Answers are grounded in this paper and cite their sources.
Underscores VTE prophylaxis gaps in cancer surgery; leaves open optimal implementation of guideline options.
Patients with cancer have an increased risk of developing venous thromboembolism (VTE) due to a hypercoagulable state associated with malignancy. This risk is further complicated in patients undergoing cancer-related surgery due to immobility, other cancer treatments, and biologic changes associated with surgery. Despite this relatively high risk of VTE, many patients are not prescribed adequate prophylaxis in the pre- or post-operative periods. This article reviews available measures for thromboprophylaxis in light of current guidelines.
No takes yet. Share an insight, caveat, or question.
David Bergqvist (2007) conducted a review in Venous thromboembolism in cancer surgery. Thromboprophylaxis was evaluated. Patients undergoing cancer surgery face a high risk of venous thromboembolism but frequently do not receive adequate thromboprophylaxis, prompting a review of available preventive measures.
Synapse has enriched 10 related papers. Consider them for comparative context: